NEWS

Left MCA M1 Occlusion treated with STAT technique

Cerus Endovascular Receives CE Mark Approvals for its Neqstent™ Coil Ass...

Fremont, California and Oxford, United Kingdom April 22, 2020 – Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its Neqstent™  Coil Assisted Flow Diverter device, designed to treat intracranial aneurysms. Neqstent™ is designed to treat a range of aneurysm morphologies including wide-necked bifurcation and bifurcation aneurysms. Neqstent™ is an adjunctive intrasaccular flow diverter device that provides stable aneurysm neck coverage for the placement of embolization coils within the sac and long-term occlusion of the aneurysm.

Right M1 occlusion with STAT technique

SNIS recommendations for neurointerventional patients treatment during COVID-19

Check out the recommendations published by the Society of NeuroInterventional Surgery for the care of emergent neurointerventional patients in the setting of COVID-19.

Covid-19: SNIS recommendations

Interventional Neuroradiology during the COVID-19 pandemic

Interventional Neuroradiology during the COVID-19 pandemic

Rodrigo Rivera, editor-in-chief of LINNC Online, explains how his hospital is preparing the arrival of the Covid-19 pandemic in Chile and shares a special protocol used in Spain.

Spinal epidural arteriovenous fistula embolization

LINNC Paris postponed!

Removal of a 11cm thrombus!